AU2629995A - Novel quinolylamine derivative, process for production thereof, and use thereof as antiarrhythmic agent - Google Patents

Novel quinolylamine derivative, process for production thereof, and use thereof as antiarrhythmic agent

Info

Publication number
AU2629995A
AU2629995A AU26299/95A AU2629995A AU2629995A AU 2629995 A AU2629995 A AU 2629995A AU 26299/95 A AU26299/95 A AU 26299/95A AU 2629995 A AU2629995 A AU 2629995A AU 2629995 A AU2629995 A AU 2629995A
Authority
AU
Australia
Prior art keywords
quinolylamine
derivative
novel
production
antiarrhythmic agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU26299/95A
Inventor
You Sup Chung
Gee Ho Jeon
Dong Ick Kim
Kab Sig Kim
Toshiro Kozono
Shigeru Tanabe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
C&C Research Laboratories
Original Assignee
C&C Research Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by C&C Research Laboratories filed Critical C&C Research Laboratories
Publication of AU2629995A publication Critical patent/AU2629995A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
AU26299/95A 1994-08-19 1995-06-07 Novel quinolylamine derivative, process for production thereof, and use thereof as antiarrhythmic agent Abandoned AU2629995A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP19567194 1994-08-19
JP6-195671 1994-08-19
PCT/JP1995/001137 WO1996006084A1 (en) 1994-08-19 1995-06-07 Novel quinolylamine derivative, process for production thereof, and use thereof as antiarrhythmic agent

Publications (1)

Publication Number Publication Date
AU2629995A true AU2629995A (en) 1996-03-14

Family

ID=16345068

Family Applications (1)

Application Number Title Priority Date Filing Date
AU26299/95A Abandoned AU2629995A (en) 1994-08-19 1995-06-07 Novel quinolylamine derivative, process for production thereof, and use thereof as antiarrhythmic agent

Country Status (3)

Country Link
KR (1) KR960007566A (en)
AU (1) AU2629995A (en)
WO (1) WO1996006084A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0927164A1 (en) 1996-09-10 1999-07-07 PHARMACIA & UPJOHN COMPANY 8-hydroxy-7-substituted quinolines as anti-viral agents
GB9711220D0 (en) * 1997-05-30 1997-07-23 Isis Innovation Antiarrhythmic agents
CA2330564A1 (en) 1998-04-29 1999-11-04 John Stephen Elder Quinolones used as mrs inhibitors and bactericides
WO2003045313A2 (en) * 2001-11-27 2003-06-05 Merck & Co. Inc. 2-aminoquinoline compounds
EP1879899B1 (en) * 2004-12-09 2010-08-04 Xention Limited Thienopyridine derivatives as potassium channel inhibitors
DK1983990T3 (en) 2006-01-26 2011-07-11 Us Gov Health & Human Serv Allosteric A3 adenosine receptor modulators
US20110144156A1 (en) * 2008-08-19 2011-06-16 Universiteit Leiden A3 adenosine receptor allosteric modulators
TW202016076A (en) * 2018-05-31 2020-05-01 南韓商Ｃ＆Ｃ新藥研究所 Heterocyclic derivatives and use thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA867508B (en) * 1985-10-03 1988-05-25 American Home Prod Substituted benzene derivatives
GB8609331D0 (en) * 1986-04-16 1986-05-21 Pfizer Ltd Anti-arrythmia agents
US4956382A (en) * 1987-02-07 1990-09-11 Pfizer Inc. Sulfonamide anti-arrhythmic agents
JPH02223558A (en) * 1988-11-02 1990-09-05 Kaken Pharmaceut Co Ltd Phenylalkylamine derivative and antifungal agent containing the same derivative as active ingredient

Also Published As

Publication number Publication date
KR960007566A (en) 1996-03-22
WO1996006084A1 (en) 1996-02-29

Similar Documents

Publication Publication Date Title
AU5642294A (en) Bacteriocidal gas composition and process for preparing the same
AU7239794A (en) Process for preparing 5,8-dihydronaphthoquinone derivatives, novel 5,8-dihydronaphthoquinone derivatives and their use as anticancer agent
EP0693474A4 (en) Novel benzylaminoethoxybenzene derivative, process for producing the same, and use thereof
HU9700566D0 (en) Amino-alkyl- and acyl-amino-alkyl-ethers, process for producing them and their use as bradiquinine-receptor-antagonists
AU6983494A (en) Indazolesulfonylurea derivative, use thereof, and intermediate for production thereof
AU6282494A (en) 4-aminopyridines, their production and use as an antithrombosis agent
AU2537695A (en) Epoxysuccinic acid derivatives, their production and use
AU2311195A (en) Novel compounds having a benzisoselen-azoline and -azine structure, method for preparing same and therapeutic uses thereof
AU2629995A (en) Novel quinolylamine derivative, process for production thereof, and use thereof as antiarrhythmic agent
AU3694795A (en) Novel oligomers, process for their preparation and methods for their use
AU3772795A (en) Polyol composition, process for its preparation and its applications
AU5895996A (en) Basic cobalt(II) carbonates, process for the production thereof and the use thereof
AU5708498A (en) Process for producing 1,1,1,2,3,3,3-heptafluoropropane
AU3255997A (en) Process for preparing 1,3-alkanediols
AU2792195A (en) Chondramides, production methods, compositions comprising chondramides and cultures for chondramide production
AU2629695A (en) Novel amine derivative, process for producing the same, and use thereof as antiarrhythmic
AU3994795A (en) Pyridylpyrrole compounds, process for production, and agrohorticultural bactericide
AU4115796A (en) Iminooxymethylene anilides, process for preparing the same and their use
AU1199495A (en) Process for producing difluoromethane and 1,1,1,2-tetrafluoroethane
AU3744495A (en) Process for preparing 1,3-alkanediols and 3-hydroxyldehydes
AU2683295A (en) Novel deaminoneuraminidase and process for producing the same
AU2742397A (en) Processes for producing 1,6-hexanedials and derivatives
AU3218195A (en) Alpha-d-pentofuranoside derivatives, process for preparing the same and their use
AU7072594A (en) Surfactant, process for its production and use
AU4386796A (en) Process for preparing aliphatic alpha,omega-aminonitriles